Published in Pharmacol Ther on January 01, 1990
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch Pharmacol (2003) 3.34
Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am J Hum Genet (1991) 1.60
Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs. Br J Clin Pharmacol (2002) 1.52
Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J (1992) 1.44
Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicin. Br J Clin Pharmacol (1990) 1.13
Inhibitors of imipramine metabolism by human liver microsomes. Br J Clin Pharmacol (1992) 1.04
Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97
Role of cytochrome P450 in drug interactions. Nutr Metab (Lond) (2008) 0.97
Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. Eur J Clin Pharmacol (2005) 0.95
Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone. Br J Clin Pharmacol (1993) 0.95
Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail. Br J Clin Pharmacol (1998) 0.91
Co-regulation of phenytoin and tolbutamide metabolism in humans. Br J Clin Pharmacol (1992) 0.91
Debrisoquine and mephenytoin oxidation in Sinhalese: a population study. Br J Clin Pharmacol (1994) 0.91
Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2. Br J Clin Pharmacol (1995) 0.90
A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatment. Br J Clin Pharmacol (2003) 0.90
Genetic polymorphisms, drug metabolism and drug concentrations. Clin Biochem Rev (2004) 0.87
Metoprolol oxidation polymorphism in a Korean population: comparison with native Japanese and Chinese populations. Br J Clin Pharmacol (1991) 0.87
Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population. Br J Clin Pharmacol (1999) 0.84
Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK-PD modelling analysis. Br J Clin Pharmacol (2001) 0.84
Influence of amino acid residue 374 of cytochrome P-450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol. Biochem J (1996) 0.84
Interethnic differences in drug glucuronidation: a comparison of paracetamol metabolism in Caucasians and Chinese. Br J Clin Pharmacol (1991) 0.84
Frequency of impaired mephenytoin 4'-hydroxylation in an Indian population. Br J Clin Pharmacol (1990) 0.83
Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis. PLoS One (2011) 0.82
Molecular heterogeneity of the XbaI defined 44kb allele of the CYP2D locus within the Caucasian population. Br J Clin Pharmacol (1993) 0.80
Urinary excretion of morphine and biosynthetic precursors in mice. Proc Natl Acad Sci U S A (2010) 0.79
Influence of CYP2D6-dependent metabolism on the steady-state pharmacokinetics and pharmacodynamics of metoprolol and nicardipine, alone and in combination. Br J Clin Pharmacol (1993) 0.78
Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotyping. J Psychiatry Neurosci (1994) 0.77
The effects of the genetic absence and inhibition of CYP2D6 on the metabolism of codeine and its derivatives, hydrocodone and oxycodone. Anesth Prog (1998) 0.77
The metabolism of aprindine in relation to the sparteine/debrisoquine polymorphism. Br J Clin Pharmacol (1993) 0.75
Rat CYP2D2, not 2D1, is functionally conserved with human CYP2D6 in endogenous morphine formation. FEBS Lett (2012) 0.75
Acute subdural hematomas: an age-dependent clinical entity. J Neurosurg (1989) 1.64
Is there a genetic factor in flecainide toxicity? BMJ (1988) 1.41
Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients. AIDS (1994) 1.12
Gliclazide hydroxylation by rat liver microsomes. Xenobiotica (1995) 0.88
Analytical validation for a series of marker compounds used to assess renal drug elimination processes. Ther Drug Monit (2001) 0.85
Relationship between proguanil metabolic ratio and CYP2C19 genotype in a Caucasian population. Br J Clin Pharmacol (1998) 0.85
The influence of the sparteine/debrisoquin phenotype on the disposition of flecainide. Clin Pharmacol Ther (1989) 0.85
Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy. Anesthesiology (1999) 0.83
Prolonged thiopentone infusion for neurosurgical emergencies: usefulness of therapeutic drug monitoring. Anaesth Intensive Care (2001) 0.81
Pharmacokinetics of thiopentone enantiomers following intravenous injection or prolonged infusion of rac-thiopentone. Br J Clin Pharmacol (1997) 0.79
A genetic variant of beta-glucuronidase in Drosophila melanogaster. J Biol Chem (1983) 0.79
The effect of liver disease and food on plasma MEGX concentrations. Br J Clin Pharmacol (1994) 0.78
Influence of environmental and genetic factors on CYP1A2 activity in individuals of South Asian and European ancestry. Clin Pharmacol Ther (2012) 0.78
Determination of ritodrine in blood and plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr (1987) 0.78
Modified high-performance liquid chromatographic method to measure both dextromethorphan and proguanil for oxidative phenotyping. J Chromatogr B Biomed Sci Appl (1997) 0.77
Acneiform eruption due to eruptive vellus hair cysts. South Med J (1992) 0.75
The effect of dipeptide structure on dipeptide and amino acid clearance in rats. Metabolism (1994) 0.75
Specimen storage and amiodarone quality assurance. Ther Drug Monit (1995) 0.75
Metabolism of dexfenfluramine in human liver microsomes and by recombinant enzymes: role of CYP2D6 and 1A2. Pharmacogenetics (1998) 0.75
Plasma protein binding of ritodrine at parturition and in nonpregnant women. Eur J Clin Pharmacol (1985) 0.75
Pyoderma gangrenosum associated with antiphospholipid antibodies. Int J Dermatol (1992) 0.75
In-vitro potencies of histamine H2-receptor antagonists on tetraethylammonium uptake in rat renal brush-border membrane vesicles. J Pharm Pharmacol (1994) 0.75
High-performance liquid chromatography-electrospray ionization mass spectrometry method for the measurement of moclobemide and two metabolites in plasma. J Chromatogr B Biomed Sci Appl (2001) 0.75
Gluten-free diet in dermatitis herpetiformis. Arch Dermatol (1991) 0.75
Foscarnet-induced penile ulcer in an uncircumcised patient with AIDS. Clin Infect Dis (1993) 0.75